microRNA signatures in peripheral blood fail to detect acute cellular rejection after liver transplantation

References

• Alqahtani SA. (2012). Update in liver transplantation. Curr Opin Gastroenterol 28:230–8.
   PubMed Web of Science ®Google Scholar
• Anglicheau D, Sharma VK Ding R, et al. (2009). MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 106:5330–5.
   PubMed Web of Science ®Google Scholar
• Duong Van Huyen JP, Tible M, Gay A, et al. (2014). MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J 35:3194–202.
   PubMed Web of Science ®Google Scholar
• Duyu M, Durmaz B Gunduz C, et al. (2014). Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia. Biomed Res Int 2014:967585.
   PubMed Web of Science ®Google Scholar
• Farid WR, Pan Q, van der Meer AJ, et al. (2012). Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 18:290–7.
   PubMed Web of Science ®Google Scholar
• Farid WR, Verhoeven CJ, de Jonge J, et al. (2014). The ins and outs of microRNAs as biomarkers in liver disease and transplantation. Transpl Int 27:1222–32.
   PubMed Web of Science ®Google Scholar
• Gehrau RC, Mas VR, Maluf DG. (2013). Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs? Expert Rev Gastroenterol Hepatol 7:157–70.
   PubMed Web of Science ®Google Scholar
• Hartono C, Muthukumar T, Suthanthiran M. (2010). Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 15:35–41.
   PubMed Web of Science ®Google Scholar
• Häusler SF, Keller A Chandran PA, et al. (2010). Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103:693–700.
   PubMed Web of Science ®Google Scholar
• Heidt S, San Segundo D Shankar S, et al. (2011). Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 92:1–9.
   PubMed Web of Science ®Google Scholar
• Hu J, Wang Z Tan CJ, et al. (2013). Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation 95:991–9.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Ander BP, Zhan X, et al. (2014). microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One 9:e99283.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Borries A, et al. (2009). miRNAs in lung cancer – studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9:353.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P Steinmeyer F, et al. (2014). Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 20:295–303.
   PubMed Web of Science ®Google Scholar
• Knechtle SJ, Kwun J. (2009). Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 29:91–101.
   PubMed Web of Science ®Google Scholar
• Leidinger P, Keller A, Borries A, et al. (2011). Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 74:41–7.
   PubMed Web of Science ®Google Scholar
• Mas VR, Dumur CI, Scian MJ, et al. (2013). MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant 13:11–19.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. (2014). Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18:371–90.
   PubMed Web of Science ®Google Scholar
• Mookherjee N, El-Gabalawy HS. (2013). High degree of correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients. J Immunol Methods 400-401:106–10.
   PubMed Web of Science ®Google Scholar
• Morris MW Jr, Anderson C. (2013). The holy grail: a biomarker for acute rejection in liver transplantation. J Surg Res 185:535–6.
   PubMed Web of Science ®Google Scholar
• Neil DA, Hübscher SG. (2010). Current views on rejection pathology in liver transplantation. Transpl Int 23:971–83.
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Kroh E Wood B, et al. (2012). Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5:492–7.
   PubMed Web of Science ®Google Scholar
• Raschzok N, Reutzel-Selke A Schmuck RB, et al. (2015). CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation. Liver Transpl 21:1195–207.
   PubMed Web of Science ®Google Scholar
• Roedder S, Vitalone M, Khatri P, Sarwal MM. (2011). Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 3:37.
   PubMed Web of Science ®Google Scholar
• Rook M, Rand E. (2011). Predictors of long-term outcome after liver transplant. Curr Opin Organ Transplant 16:499–504.
   PubMed Web of Science ®Google Scholar
• Sánchez-Fueyo A, Strom TB. (2011). Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140:51–64.
   PubMed Web of Science ®Google Scholar
• Schoening WN, Buescher N, Rademacher S, et al. (2013). Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases. Am J Transplant 13:2384–94.
   PubMed Web of Science ®Google Scholar
• Schultz NA, Dehlendorff C, Jensen BV, et al. (2014). MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 311:392–404.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Patric IR, Somasundaram K. (2011). A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 6:e17438.
   PubMed Web of Science ®Google Scholar
• Lewis PJS, Dear J, Platt V, et al. (2011). Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54:1767–76.
   PubMed Web of Science ®Google Scholar
• Wang X, Cao L, Wang Y, et al. (2012). Regulation of let-7 and its target oncogenes (Review). Oncol Lett 3:955–60.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Dai Y. (2014). Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 23:347–55.
   PubMed Web of Science ®Google Scholar